Tagged with Internationalization

Mexico Enrique Carballido, general manager Mexico and Latin South America at Bio-Rad, showcases Bio-Rad’s offering in both diagnostics and life sciences and the crucial role of the entire industry in helping public health institutions more effectively allocate their resources based on the number of patients covered and the economical savings obtained.…

Greece Carrying the legacy of an accomplished Greek family business, Anfarm CEO Eugenia Nicolaou speaks proudly about the company’s evolution, how Anfarm is maintaining a sustainable business model in the midst of the economic crisis, and how it is building a stronger presence in the international landscape. Anfarm is a Greek…

Pharma Angelini CEO Gianluigi Frozzi speaks about the company’s diverse portfolio of products, the “Made in Italy” brand, and the company’s continual global growth anchored strongly in innovation. Can you please give our readers an overview of Angelini’s operations, both globally and locally? First, I want to explain to our audience that Angelini…

Pharma Gnosis is a fully vertically integrated biotech company specialized in the manufacturing and sales of fermentation raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary, and agricultural industries. The business development director shares the company’s future plans to strengthen its international footprint. Given your experience, what…

Pharma Eric Ducournau, CEO of Pierre Fabre Dermo-Cosmétique (PFDC), discusses the company’s revolutionary lines of dermatologically tested skincare products and their niche adapted internationalization strategy that is focused on providing the highest-quality skincare products for all consumer and patient needs. The Dermo-Cosmetics division of Pierre Fabre has represented about 55 percent…

Pharma Dr. Osvaldo Ponchiroli, CEO of OP Pharma, discusses the expertise his company can offer to help navigate Italy’s regulatory environment, the outlook for medium-sized generics companies in Italy and OP’s plans for international expansion. Dr. Ponchiroli, you founded OP pharma in 1996 as a data management and generics company mainly…

Pharma Family-owned Laboratori Baldacci is something of a rare breed in an industry dominated by multinational players. The senior research manager discusses the history of the company as well as how it plans to leverage its portfolio of innovative products and internationalization to drive growth in future. Could you please provide…

Pharma Juan Sénquiz, President and CEO of JC Automation, weighs in on the capacity of Puerto Rico’s local pharma service industry to grow globally and how the company’s computerized systems services have helped some of the biggest names in the industry to automate more effectively. We have seen a lot of…

women's health Leandro Sigman, general manager of Chemo, discusses changes in the Spanish market and the company’s strategy to target international markets.   The crisis has changed the way companies operate in Spain, but Chemo has continued to succeed. What have been some of the key strategies employed? It has been a…

Internationalization José Fernández, president of the Zeltia Group, outlines the company’s strategy for developing oncology drugs through marine-based organisms with the group’s subsidiary PharmaMar. With €550 [SG1] million invested in research and development in total, Zeltia was finally able to commercialize a novel product.  Would you say that this investment was worth…

Internationalization The history of AmCham Spain dates back to 1917 and has a critical part of developing bilateral relations between Spain and the United States. The company’s president, Jaime Malet, discusses AmCham Spain’s ongoing efforts to attract investment by American companies in Spain today. What are AmCham’s greatest challenges today? The…